Plain-English translation of NCT06136351 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing , a new type of cancer-fighting drug, combined with two other medications (bendamustine and ) that are already used to treat mantle cell lymphoma. The study wants to see if this three-drug combination works well and is safe, especially for older patients or those whose bodies don't handle standard chemotherapy well.
Mantle cell lymphoma is a serious blood cancer that is hard to treat, and some patients cannot tolerate the strongest chemotherapy options. This trial exists to find a gentler but still effective treatment approach for these patients.
You likely qualify if…
You likely don't qualify if…
As a participant, you would receive the three-drug combination (, bendamustine, and ) according to a treatment schedule designed by the research team. You would have regular clinic visits for physical exams, blood tests, and scans to see how well the treatment is working and to check for any side effects. The trial will follow about 23 patients to learn whether this combination is effective and safe for people with your condition.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China